News About: Pharm. Industry


President Chan-Hwi Cho, “We will focus on issues with household drugs, drug dispensers and civic affairs”

President Chan-Hwi Cho of the Korean Pharmaceutical Association held the ‘2017 New Year Press Conference’ the association’s press corps. In regards to the new year’s work plan, President Cho announced “The regulatory...

Multinational pharmas’s series of administrative actions from MFDS

Multinational pharmaceutical companies have received administrative measures from the Ministry of Food and Drug Safety(MFDS) for violating related regulations, such as the Pharmaceutical Affairs Law. UCB Korea receiv...

Leo Pharma’s Enstiloom acquires approval as psoriasis treatment in Korea

On the 16th, Leo Pharma Korea(President Kasper Kunzel) announced Enstiloom(generic name: calcipotriol/betamethasone dipropionate 50 micrograms/g / 0.643 mg/g), an external aerosol-form-type psoriasis treatment was rec...

Kyowa Hakko Kirin CEO visits to Korea, “It’s time to take off for our goal”

President Nobuo Hanai, CEO of Japanese Kyowa Hakko Kirin, visited Korea on the 10th. It has been a year since his last visit when suggesting ‘2020 Vision’ on December 2015. President Hanai, who proposed directions an...

Kyeong-Ho Lee announces resignation from KPMA Chairman

Chairman Kyeong-Ho Lee of the Korea Pharmaceutical Manufacturers Association(KPMA) will resign from this position a regular general meeting on the coming February. Chairman Kyeong-Ho Lee announced the resignation at ...

What will be changed after resignation of Chairman Kyeong-Ho Lee

Leaving a year left for his term of office, Chairman Kyeong-Ho Lee of the Korea Pharmaceutical Manufacturers Association(KPMA) announced resignation on the 12th, which attracted attention of the industry over the asso...

Opinion differences between prosecution and Novartis at rebate trial

Acceptance or denial of the Novartis’ case in which the company was charged for a new concept of illegal rebate provision through the mass media and PR agencies has not been dec...

Hanmi Pharm introduces platform technology & new drug pipeline at JP Morgan Conference

On the 12th, Hanmi Pharm(CEO Kwan-Soon Lee) announced it was revealed the 2017 R&D strategy at the ‘35th JP Morgan Healthcare Conference’ held at Westin St. Francis in San Franc...

LegoChem Bio signs ADC research license agreement with Takeda

LegoChem Biosciences(hereinafter referring to LegoChem Bio) announced it signed a ADC(antibody-drug ) research license agreement with Takeda on the 11th of January. This is the first license agreement with a global ph...

60 2nd & 3rd generations running pharmaceutical companies

While 2nd and 3rd generations have actively operated pharmaceutical companies, there were 60 owner-family executives born in later than 1960. Particularly, 13 2nd, 3rd and 4th generations of the owner family were prom...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.